Overview

Efficacy of Trial-Based Cognitive Therapy and Behavioral Activation in Treatment of Depression

Status:
Unknown status
Trial end date:
2017-12-01
Target enrollment:
0
Participant gender:
All
Summary
Major Depressive Disorder (MDD) is a mood disorder, highly prevalent in Brazil and in world. The treatments of choice are the psychotropic drugs of the class of antidepressants and Behavioral or Cognitive Behavior Therapy (CBT). The aim of this study is to compare the efficacy of Trial Based Cognitive Therapy with the Behavioral Activation and pharmacotherapy in the treatment of MDD in a randomized clinical trial witch 96 patients with MDD,
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Hemanny, Curt, M.D.
Collaborator:
Federal University of Bahia
Treatments:
Antidepressive Agents
Criteria
Inclusion Criteria:

- Major Depressive Disorder

- Both Genres

- Minimum of 20 in BDI Score

- Refractory depressive disorder

Exclusion Criteria:

- Bipolar disorder

- High risk of suicide

- Borderline personality